CRONOS GROUP INC. Increase (Decrease) in Accrued Liabilities
CRONOS GROUP INC. (CRON) reported Increase (Decrease) in Accrued Liabilities of -$479.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- CRONOS GROUP INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $4.66M, a 438.73% increase year-over-year.
- CRONOS GROUP INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$5.14M.
- CRONOS GROUP INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $6.17M, a 411.02% increase year-over-year.
- CRONOS GROUP INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $4.28M, a 13.46% decline year-over-year.
- CRONOS GROUP INC. increase (decrease) in accrued liabilities for fiscal 2025 was $2.44M, a 14.15% decline from fiscal 2024.
- CRONOS GROUP INC. increase (decrease) in accrued liabilities for fiscal 2024 was $2.84M, a 44.96% decline from fiscal 2023.
- CRONOS GROUP INC. increase (decrease) in accrued liabilities for fiscal 2023 was $5.16M.
- CRONOS GROUP INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$2.92M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$479.00K 10-Q · filed 2026-08-06 | $5.69M derived: sum of 3 quarters · filed 2026-08-06 | $9.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$5.14M 10-Q · filed 2026-05-11 | $1.03M derived: sum of 2 quarters · filed 2026-05-11 | $5.31M derived: sum of 3 quarters · filed 2026-05-11 | $6.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.45M derived: sum of 2 quarters · filed 2026-02-26 | $11.32M derived: sum of 3 quarters · filed 2026-08-06 | $2.44M 10-K · filed 2026-02-26 |
| 2025-09-30 | $4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.15M derived: sum of 2 quarters · filed 2026-08-06 | -$3.73M 10-Q · filed 2025-11-06 | -$2.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $865.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.01M 10-Q · filed 2026-08-06 | -$6.81M derived: sum of 3 quarters · filed 2026-08-06 | -$1.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$8.88M 10-Q · filed 2026-05-11 | -$7.67M derived: sum of 2 quarters · filed 2026-05-11 | -$2.72M derived: sum of 3 quarters · filed 2026-05-11 | -$976.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.16M derived: sum of 2 quarters · filed 2026-02-26 | $7.90M derived: sum of 3 quarters · filed 2026-02-26 | $2.84M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.70M derived: sum of 2 quarters · filed 2025-11-06 | $1.63M 10-Q · filed 2025-11-06 | $4.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.32M 10-Q · filed 2025-08-07 | -$66.00K derived: sum of 3 quarters · filed 2026-02-26 | $7.63M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$5.06M 10-Q · filed 2025-05-08 | -$1.81M derived: sum of 2 quarters · filed 2026-02-26 | $5.88M derived: sum of 3 quarters · filed 2026-02-26 | $7.99M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.94M derived: sum of 2 quarters · filed 2026-02-26 | $13.05M derived: sum of 3 quarters · filed 2026-02-26 | $5.16M 10-K · filed 2026-02-26 |
| 2023-09-30 | $7.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $9.80M derived: sum of 2 quarters · filed 2024-11-12 | $1.91M 10-Q · filed 2024-11-12 | -$921.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$5.78M 10-Q · filed 2024-08-08 | -$8.62M derived: sum of 3 quarters · filed 2025-02-27 | -$7.18M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$7.89M 10-Q · filed 2024-05-09 | -$10.72M derived: sum of 2 quarters · filed 2025-02-27 | -$9.29M derived: sum of 3 quarters · filed 2025-02-27 | -$7.67M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.40M derived: sum of 2 quarters · filed 2025-02-27 | $229.00K derived: sum of 3 quarters · filed 2025-02-27 | -$2.92M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.06M derived: sum of 2 quarters · filed 2023-11-08 | -$90.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$1.52M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$3.15M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$4.97M 10-K · filed 2024-02-29 | |||
| 2021-03-31 | -$10.17M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $5.05M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $12.60M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |